Aquabounty Technologies (AQB) Lowered to “Sell” at Zacks Investment Research

Zacks Investment Research cut shares of Aquabounty Technologies (NASDAQ:AQB) from a hold rating to a sell rating in a report released on Friday.

According to Zacks, “AquaBounty Technologies, Inc. is a biotechnology company. It focused on enhancing productivity in aquaculture. The company operates primarily in Maynard, Massachusetts and Fortune, Prince Edward Island. AquaBounty Technologies, Inc. is based in Maynard, United States. “

A number of other analysts also recently issued reports on the stock. HC Wainwright set a $4.00 price target on shares of Aquabounty Technologies and gave the stock a buy rating in a report on Wednesday, November 28th. ValuEngine upgraded shares of Aquabounty Technologies from a hold rating to a buy rating in a report on Wednesday, November 7th.

AQB stock traded up $0.06 during mid-day trading on Friday, reaching $2.44. The company’s stock had a trading volume of 16,223 shares, compared to its average volume of 26,055. The company has a market cap of $35.94 million, a price-to-earnings ratio of -2.30 and a beta of -0.66. The company has a current ratio of 0.98, a quick ratio of 0.94 and a debt-to-equity ratio of 0.14. Aquabounty Technologies has a fifty-two week low of $2.25 and a fifty-two week high of $9.99.

Aquabounty Technologies (NASDAQ:AQB) last announced its quarterly earnings results on Friday, November 2nd. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.20) by ($0.01). The firm had revenue of $0.01 million for the quarter, compared to analyst estimates of $0.14 million. As a group, equities analysts forecast that Aquabounty Technologies will post -0.87 earnings per share for the current year.

A hedge fund recently raised its stake in Aquabounty Technologies stock. ARK Investment Management LLC increased its stake in shares of Aquabounty Technologies Inc (NASDAQ:AQB) by 81.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 170,697 shares of the company’s stock after purchasing an additional 76,458 shares during the period. ARK Investment Management LLC owned approximately 1.33% of Aquabounty Technologies worth $568,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 54.25% of the company’s stock.

About Aquabounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, develops and markets products to enhance productivity in aquaculture. It offers AquAdvantage Salmon, a genetically modified Atlantic salmon for human consumption. The company was formerly known as Aqua Bounty Farms, Inc and changed its name to AquaBounty Technologies, Inc in June 2004.

Featured Story: Reverse Stock Split

Get a free copy of the Zacks research report on Aquabounty Technologies (AQB)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Aquabounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aquabounty Technologies and related companies with's FREE daily email newsletter.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit